Document is current

Any future updates will be listed below

Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis

Crossref DOI link: https://doi.org/10.1186/s12879-016-2056-3

Published Online: 2016-11-29

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark